Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giancarlo Marenzi

Showing results (1-10 of 172) with videos related to

Pageof 18
Sort By:
Nature Clinical Practice. Nephrology|December 7, 2007
Prophylactic hemodialysis for the prevention of contrast-induced nephropathy after coronary angiographyGiancarlo Marenzi
Giornale Italiano Di Cardiologia (2006)|April 8, 2009
[Prevention of contrast-induced nephropathy and management of high-risk patients]Giancarlo Marenzi
Nature Clinical Practice. Cardiovascular Medicine|November 3, 2005
Can contrast-induced nephropathy after percutaneous coronary intervention be accurately predicted with a risk score?Giancarlo Marenzi
JACC. Heart Failure|April 2, 2016
The AVOID-HF Trial: Points to ConsiderGiancarlo Marenzi, Amir Kazory
Journal of the American College of Cardiology|March 19, 2013
Ultrafiltration in refractory heart failureGiancarlo Marenzi, Nadia Aspromonte
Giornale Italiano Di Cardiologia (2006)|April 4, 2015
[Fenoldopam in patients with acute kidney injury after cardiac surgery]Giancarlo Marenzi, Roberto Paino
JACC. Cardiooncology|April 17, 2025
Enalapril for Preventing Cardiotoxicity After High-Dose Anthracycline Therapy in Breast Cancer and Lymphoma PatientsDaniela Cardinale, Giancarlo Marenzi
Journal of Clinical Pharmacology|January 15, 2011
N-acetylcysteine for the prevention of acute kidney injury after cardiac surgeryErminio Sisillo, Giancarlo Marenzi
Giornale Italiano Di Cardiologia (2006)|December 17, 2013
[The PRATO-ACS study]Giancarlo Marenzi, Carlo Briguori
European Heart Journal|August 7, 2007
Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trialGiancarlo Marenzi, Antonio L Bartorelli
Pageof 18

Showing results (1-10 of 172) with videos related to

Sort By:
Pageof 18
Nature Clinical Practice. Nephrology|December 7, 2007
Prophylactic hemodialysis for the prevention of contrast-induced nephropathy after coronary angiographyGiancarlo Marenzi
Giornale Italiano Di Cardiologia (2006)|April 8, 2009
[Prevention of contrast-induced nephropathy and management of high-risk patients]Giancarlo Marenzi
Nature Clinical Practice. Cardiovascular Medicine|November 3, 2005
Can contrast-induced nephropathy after percutaneous coronary intervention be accurately predicted with a risk score?Giancarlo Marenzi
JACC. Heart Failure|April 2, 2016
The AVOID-HF Trial: Points to ConsiderGiancarlo Marenzi, Amir Kazory
Journal of the American College of Cardiology|March 19, 2013
Ultrafiltration in refractory heart failureGiancarlo Marenzi, Nadia Aspromonte
Giornale Italiano Di Cardiologia (2006)|April 4, 2015
[Fenoldopam in patients with acute kidney injury after cardiac surgery]Giancarlo Marenzi, Roberto Paino
JACC. Cardiooncology|April 17, 2025
Enalapril for Preventing Cardiotoxicity After High-Dose Anthracycline Therapy in Breast Cancer and Lymphoma PatientsDaniela Cardinale, Giancarlo Marenzi
Journal of Clinical Pharmacology|January 15, 2011
N-acetylcysteine for the prevention of acute kidney injury after cardiac surgeryErminio Sisillo, Giancarlo Marenzi
Giornale Italiano Di Cardiologia (2006)|December 17, 2013
[The PRATO-ACS study]Giancarlo Marenzi, Carlo Briguori
European Heart Journal|August 7, 2007
Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trialGiancarlo Marenzi, Antonio L Bartorelli
Pageof 18